-
1
-
-
0024329881
-
The biochemistry of P-glycoprotein-mediated multidrug-resistance
-
Endicott, J. A.; Ling, V. The biochemistry of P-glycoprotein-mediated multidrug-resistance Annu. Rev. Biochem. 1989, 58, 137-171
-
(1989)
Annu. Rev. Biochem.
, vol.58
, pp. 137-171
-
-
Endicott, J.A.1
Ling, V.2
-
2
-
-
0027218689
-
Biochemistry of multidrug resistance mediated by the multidrug transporter
-
Gottesman, M. M.; Pastan, I. Biochemistry of multidrug resistance mediated by the multidrug transporter Annu. Rev. Biochem. 1993, 62, 385-427 (Pubitemid 23237876)
-
(1993)
Annual Review of Biochemistry
, vol.62
, pp. 385-427
-
-
Gottesman, M.M.1
Pastan, I.2
-
3
-
-
0027095653
-
Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line
-
Cole, S. P. C.; Bhardwaj, G.; Gerlach, J. H.; Mackie, J. E.; Grant, C. E.; Almquist, K. C.; Stewart, A. J.; Kurz, E. U.; Duncan, A. M. V.; Deeley, R. G. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line Science 1993, 258, 1650-1654
-
(1993)
Science
, vol.258
, pp. 1650-1654
-
-
Cole, S.P.C.1
Bhardwaj, G.2
Gerlach, J.H.3
MacKie, J.E.4
Grant, C.E.5
Almquist, K.C.6
Stewart, A.J.7
Kurz, E.U.8
Duncan, A.M.V.9
Deeley, R.G.10
-
4
-
-
0032404092
-
A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance
-
Allikmets, R.; Schriml, L. M.; Hutchinson, A.; Romano-Spica, V.; Dean, M. A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance Cancer Res. 1998, 58, 5337-5339 (Pubitemid 28551112)
-
(1998)
Cancer Research
, vol.58
, Issue.23
, pp. 5337-5339
-
-
Allikmets, R.1
Schriml, L.M.2
Hutchinson, A.3
Romano-Spica, V.4
Dean, M.5
-
5
-
-
13044249156
-
A multidrug resistance transporter from human MCF-7 breast cancer cells
-
DOI 10.1073/pnas.95.26.15665
-
Doyle, L. A.; Yang, W.; Abruzzo, L. V.; Krogmann, T.; Gao, Y.; Rishi, A. K.; Ross, D. D. A multidrug resistance transporter from human MCF-7 breast cancer cells Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 15665-15670 (Pubitemid 29018757)
-
(1998)
Proceedings of the National Academy of Sciences of the United States of America
, vol.95
, Issue.26
, pp. 15665-15670
-
-
Austin Doyle, L.1
Yang, W.2
Abruzzo, L.V.3
Krogmann, T.4
Gao, Y.5
Rishi, A.K.6
Ross, D.D.7
-
6
-
-
0032895533
-
Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: Demonstration of homology to ABC transport genes
-
Miyake, K.; Mickley, L.; Litman, T.; Zhan, Z.; Robey, R.; Cristensen, B.; Brangi, M.; Greenberger, L.; Dean, M.; Fojo, T.; Bates, S. E. Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes Cancer Res. 1999, 59, 8-13 (Pubitemid 29062946)
-
(1999)
Cancer Research
, vol.59
, Issue.1
, pp. 8-13
-
-
Miyake, K.1
Mickley, L.2
Litman, T.3
Zhan, Z.4
Robey, R.5
Cristensen, B.6
Brangi, M.7
Greenberger, L.8
Dean, M.9
Fojo, T.10
Bates, S.E.11
-
7
-
-
33646087883
-
Inhibitors of cancer cell multidrug resistance mediated by breast cancer resistance protein (BCRP/ABCG2)
-
Ahmed-Belkacem, A.; Pozza, A.; Macalou, S.; Perez-Victoria, J. M.; Di Pietro, A. Inhibitors of cancer cell multidrug resistance mediated by breast cancer resistance protein (BCRP/ABCG2) Anticancer Drugs 2006, 17, 239-243
-
(2006)
Anticancer Drugs
, vol.17
, pp. 239-243
-
-
Ahmed-Belkacem, A.1
Pozza, A.2
MacAlou, S.3
Perez-Victoria, J.M.4
Di Pietro, A.5
-
8
-
-
79961092422
-
Targeting the multidrug ABCG2 transporter with flavonoidic inhibitors: In vitro optimization and in vivo validation
-
Boumendjel, A.; Macalou, S.; Valdameri, G.; Pozza, A.; Gauthier, C.; Arnaud, O.; Nicolle, E.; Magnard, S.; Falson, P.; Terreux, R.; Carrupt, P.-A.; Payen, L.; Di Pietro, A. Targeting the multidrug ABCG2 transporter with flavonoidic inhibitors: In vitro optimization and in vivo validation Curr. Med. Chem. 2011, 18, 3387-3401
-
(2011)
Curr. Med. Chem.
, vol.18
, pp. 3387-3401
-
-
Boumendjel, A.1
MacAlou, S.2
Valdameri, G.3
Pozza, A.4
Gauthier, C.5
Arnaud, O.6
Nicolle, E.7
Magnard, S.8
Falson, P.9
Terreux, R.10
Carrupt, P.-A.11
Payen, L.12
Di Pietro, A.13
-
9
-
-
0032535004
-
Reversal of a novel multidrug resistance mechanism in human colon carcinoma cells by fumitremorgin C
-
Rabindran, S. K.; He, H.; Singh, M.; Brown, E.; Collins, K. I.; Annable, T.; Greenberger, L. M. Reversal of a novel multidrug resistance mechanism in human colon carcinoma cells by fumitremorgin C Cancer Res. 1998, 58, 5850-5858 (Pubitemid 29006428)
-
(1998)
Cancer Research
, vol.58
, Issue.24
, pp. 5850-5858
-
-
Rabindran, S.K.1
He, H.2
Singh, M.3
Brown, E.4
Collins, K.I.5
Annable, T.6
Greenberger, L.M.7
-
10
-
-
0035825346
-
Inhibition of BCRP-mediated drug efflux by fumitremorgin-type indolyl diketopiperazines
-
DOI 10.1016/S0960-894X(00)00588-6, PII S0960894X00005886
-
van Loevezijn, A.; Allen, J. D.; Schinkel, A. H.; Koomen, G. J. Inhibition of BCRP-mediated drug efflux by fumitremorgin-type indolyl diketopiperazines Bioorg. Med. Chem. Lett. 2001, 11, 29-32 (Pubitemid 32006117)
-
(2001)
Bioorganic and Medicinal Chemistry Letters
, vol.11
, Issue.1
, pp. 29-32
-
-
Van Loevezijn, A.1
Allen, J.D.2
Schinkel, A.H.3
Koomen, G.-J.4
-
11
-
-
0000890967
-
Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C
-
Allen, J. D.; van Loevezijn, A.; Lakhai, J. M.; van der Valk, M.; van Tellingen, O.; Reid, G.; Schellens, J. H. M.; Koomen, G. J.; Schinkel, A. H. Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C Mol. Cancer Ther. 2002, 1, 417-425
-
(2002)
Mol. Cancer Ther.
, vol.1
, pp. 417-425
-
-
Allen, J.D.1
Van Loevezijn, A.2
Lakhai, J.M.3
Van Der Valk, M.4
Van Tellingen, O.5
Reid, G.6
Schellens, J.H.M.7
Koomen, G.J.8
Schinkel, A.H.9
-
12
-
-
0032695270
-
Reversal of resistance by GF120918 in cell lines expressing the ABC half-transporter, MXR
-
DOI 10.1016/S0304-3835(99)00182-2, PII S0304383599001822
-
de Bruin, M.; Miyake, K.; Litman, T.; Robey, R. W.; Bates, S. E. Reversal of resistance by GF120918 in cell lines expressing the ABC half-transporter, MXR Cancer Lett. 1999, 146, 117-126 (Pubitemid 29492880)
-
(1999)
Cancer Letters
, vol.146
, Issue.2
, pp. 117-126
-
-
De Bruin, M.1
Miyake, K.2
Litman, T.3
Robey, R.4
Bates, S.E.5
-
13
-
-
1242293677
-
Pheophorbide a Is a Specific Probe for ABCG2 Function and Inhibition
-
DOI 10.1158/0008-5472.CAN-03-3298
-
Robey, R. W.; Steadman, K.; Polgar, O.; Morisaki, K.; Blayney, M.; Mistry, P.; Bates, S. E. Pheophorbide a is a specific probe for ABCG2 function and inhibition Cancer Res. 2004, 64, 1242-1246 (Pubitemid 38235589)
-
(2004)
Cancer Research
, vol.64
, Issue.4
, pp. 1242-1246
-
-
Robey, R.W.1
Steadman, K.2
Polgar, O.3
Morisaki, K.4
Blayney, M.5
Mistry, P.6
Bates, S.E.7
-
14
-
-
64349122714
-
Potent and selective inhibitors of breast cancer resistance protein (ABCG2) derived from the p-glycoprotein (ABCB1) modulator tariquidar
-
Kühnle, M.; Egger, M.; Muller, C.; Mahringer, A.; Bernhardt, G.; Fricker, G.; Konig, B.; Buschauer, A. Potent and selective inhibitors of breast cancer resistance protein (ABCG2) derived from the p-glycoprotein (ABCB1) modulator tariquidar J. Med. Chem. 2009, 52, 1190-1197
-
(2009)
J. Med. Chem.
, vol.52
, pp. 1190-1197
-
-
Kühnle, M.1
Egger, M.2
Muller, C.3
Mahringer, A.4
Bernhardt, G.5
Fricker, G.6
Konig, B.7
Buschauer, A.8
-
15
-
-
72049094261
-
Novel lead for potent inhibitors of breast cancer resistance protein (BCRP)
-
Pick, A.; Müller, H.; Wiese, M. Novel lead for potent inhibitors of breast cancer resistance protein (BCRP) Bioorg. Med. Chem. Lett. 2010, 20, 180-183
-
(2010)
Bioorg. Med. Chem. Lett.
, vol.20
, pp. 180-183
-
-
Pick, A.1
Müller, H.2
Wiese, M.3
-
16
-
-
33947149142
-
Acridone derivatives: Design, synthesis, and inhibition of breast cancer resistance protein ABCG2
-
DOI 10.1016/j.bmc.2007.02.017, PII S0968089607001186
-
Boumendjel, A.; Macalou, S.; Ahmed-Belkacem, A.; Blanc, M.; Di Pietro, A. Acridone derivatives: design, synthesis, and inhibition of breast cancer resistance protein ABCG2 Bioorg. Med. Chem. 2007, 15, 2892-2897 (Pubitemid 46402973)
-
(2007)
Bioorganic and Medicinal Chemistry
, vol.15
, Issue.8
, pp. 2892-2897
-
-
Boumendjel, A.1
Macalou, S.2
Ahmed-Belkacem, A.3
Blanc, M.4
Di Pietro, A.5
-
17
-
-
79851507620
-
The acridone derivative MBLI-87 sensitizes breast cancer resistance protein-expressing xenografts to irinotecan
-
Arnaud, O.; Boumendjel, A.; Gèze, A.; Honorat, M.; Matera, E. L.; Guitton, J.; Stein, W. D.; Bates, S. E.; Falson, P.; Dumontet, C.; Di Pietro, A.; Payen, L. The acridone derivative MBLI-87 sensitizes breast cancer resistance protein-expressing xenografts to irinotecan Eur. J. Cancer 2011, 47, 640-648
-
(2011)
Eur. J. Cancer
, vol.47
, pp. 640-648
-
-
Arnaud, O.1
Boumendjel, A.2
Gèze, A.3
Honorat, M.4
Matera, E.L.5
Guitton, J.6
Stein, W.D.7
Bates, S.E.8
Falson, P.9
Dumontet, C.10
Di Pietro, A.11
Payen, L.12
-
18
-
-
28544452258
-
Piperazinobenzopyranones and phenalkylaminobenzopyranones: Potent inhibitors of breast cancer resistance protein (ABCG2)
-
DOI 10.1021/jm050705h
-
Boumendjel, A.; Nicolle, E.; Moraux, T.; Gerby, B.; Blanc, M.; Ronot, X.; Boutonnat, J. Piperazinobenzopyranones and phenalkylaminobenzopyranones: potent inhibitors of breast cancer resistance protein (ABCG2) J. Med. Chem. 2005, 48, 7275-7281 (Pubitemid 41743640)
-
(2005)
Journal of Medicinal Chemistry
, vol.48
, Issue.23
, pp. 7275-7281
-
-
Boumendjel, A.1
Nicolle, E.2
Moraux, T.3
Gerby, B.4
Blanc, M.5
Ronot, X.6
Boutonnat, J.7
-
19
-
-
0038248843
-
Modulation of P-glycoprotein-mediated multidrug resistance by flavonoid derivatives and analogues
-
DOI 10.1021/jm021099i
-
Hadjeri, M.; Barbier, M.; Ronot, X.; Mariotte, A.-M.; Boumendjel, A.; Boutonnat, J. Modulation of P-glycoprotein-mediated multidrug resistance by flavonoid derivatives and analogues J. Med. Chem. 2003, 46, 2125-2131 (Pubitemid 36583492)
-
(2003)
Journal of Medicinal Chemistry
, vol.46
, Issue.11
, pp. 2125-2131
-
-
Hadjeri, M.1
Barbier, M.2
Ronot, X.3
Mariotte, A.-M.4
Boumendjel, A.5
Boutonnat, J.6
-
20
-
-
19644378841
-
Flavonoid structure-activity studies identify 6-prenylchrysin and tectochrysin as potent and specific inhibitors of breast cancer resistance protein ABCG2
-
DOI 10.1158/0008-5472.CAN-04-1817
-
Ahmed-Belkacem, A.; Pozza, A.; Munoz-Martinez, F.; Bates, S. E.; Castanys, S.; Gamarro, F.; Di Pietro, A.; Pérez-Victoria, J. M. Flavonoid structure-activity studies identify 6-prenylchrysin and tectochrysin as potent and specific inhibitors of breast cancer resistance protein ABCG2 Cancer Res. 2005, 65, 4852-4860 (Pubitemid 40740824)
-
(2005)
Cancer Research
, vol.65
, Issue.11
, pp. 4852-4860
-
-
Ahmed-Belkacem, A.1
Pozza, A.2
Munoz-Martinez, F.3
Bates, S.E.4
Castanys, S.5
Gamarro, F.6
Pietro, A.D.7
Perez-Victoria, J.M.8
-
21
-
-
34247225559
-
Nonprenylated rotenoids, a new class of potent breast cancer resistance protein inhibitors
-
DOI 10.1021/jm061450q
-
Macalou, S.; Ahmed-Belkacem, A.; Borelli, F.; Capasso, R.; Fattorusso, E.; Taglialatela-Scafati, O.; Di Pietro, A. Non-prenylated rotenoids, a new class of potent breast cancer resistance protein inhibitors J. Med. Chem. 2007, 50, 1933-1938 (Pubitemid 46626602)
-
(2007)
Journal of Medicinal Chemistry
, vol.50
, Issue.8
, pp. 1933-1938
-
-
Ahmed-Belkacem, A.1
Macalou, S.2
Borrelli, F.3
Capasso, R.4
Fattorusso, E.5
Taglialatela-Scafati, O.6
Di Pietro, A.7
-
22
-
-
67650220889
-
Breast cancer resistance protein (BCRP/ABCG2): New inhibitors and QSAR studies by a 3D linear solvation-energy approach
-
Nicolle, E.; Boccard, J.; Guilet, D.; Dijoux, M.-G.; Zelefac, F.; Macalou, S.; Grosselin, J.; Schmidt, J.; Carrupt, P.-A.; Di Pietro, A.; Boumendjel, A. Breast cancer resistance protein (BCRP/ABCG2): New inhibitors and QSAR studies by a 3D linear solvation-energy approach Eur. J. Pharm. Sci. 2009, 38, 39-46
-
(2009)
Eur. J. Pharm. Sci.
, vol.38
, pp. 39-46
-
-
Nicolle, E.1
Boccard, J.2
Guilet, D.3
Dijoux, M.-G.4
Zelefac, F.5
MacAlou, S.6
Grosselin, J.7
Schmidt, J.8
Carrupt, P.-A.9
Di Pietro, A.10
Boumendjel, A.11
-
23
-
-
59049099685
-
QSAR analysis and molecular modeling of ABCG2-specific inhibitors
-
Nicolle, E.; Boumendjel, A.; Macalou, S.; Genoux, E.; Ahmed-Belkacem, A.; Carrupt, P.-A.; Di Pietro, A. QSAR analysis and molecular modeling of ABCG2-specific inhibitors Adv. Drug Pharm. Sci. 2009, 61, 34-46
-
(2009)
Adv. Drug Pharm. Sci.
, vol.61
, pp. 34-46
-
-
Nicolle, E.1
Boumendjel, A.2
MacAlou, S.3
Genoux, E.4
Ahmed-Belkacem, A.5
Carrupt, P.-A.6
Di Pietro, A.7
-
24
-
-
79952455438
-
Structure-activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP)
-
Pick, A.; Müller, H.; Mayer, R.; Haenisch, B.; Pajeva, I. K.; Weigt, M.; Bönisch, H.; Müller, C. E.; Wiese, M. Structure-activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP) Bioorg. Med. Chem. 2011, 19, 2090-2102
-
(2011)
Bioorg. Med. Chem.
, vol.19
, pp. 2090-2102
-
-
Pick, A.1
Müller, H.2
Mayer, R.3
Haenisch, B.4
Pajeva, I.K.5
Weigt, M.6
Bönisch, H.7
Müller, C.E.8
Wiese, M.9
-
25
-
-
84856376711
-
Methoxy stilbenes as potent, specific, untransported and noncytotoxic inhibitors of breast cancer resistance protein
-
in press.
-
Valdameri, G.; Pereira Rangel, L.; Sapatafora, C.; Guitton, J.; Gauthier, C.; Arnaud, O.; Ferreira-Pereira, A.; Falson, P.; Winnischofer, S. M. B.; Rocha, M. E. M.; Tringali, C.; Di Pietro, A. Methoxy stilbenes as potent, specific, untransported and noncytotoxic inhibitors of breast cancer resistance protein. ACS Chem. Biol. 2011, in press.
-
(2011)
ACS Chem. Biol.
-
-
Valdameri, G.1
Pereira Rangel, L.2
Sapatafora, C.3
Guitton, J.4
Gauthier, C.5
Arnaud, O.6
Ferreira-Pereira, A.7
Falson, P.8
Winnischofer, S.M.B.9
Rocha, M.E.M.10
Tringali, C.11
Di Pietro, A.12
-
26
-
-
7244232706
-
Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump
-
DOI 10.1182/blood-2004-04-1398
-
Burger, H.; van Tol, H.; Boersma, A. W.; Brok, M.; Wiemer, E. A.; Stoter, G.; Nooter, K. Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump Blood 2004, 104, 2940-2942 (Pubitemid 39434984)
-
(2004)
Blood
, vol.104
, Issue.9
, pp. 2940-2942
-
-
Burger, H.1
Van Tol, H.2
Boersma, A.W.M.3
Brok, M.4
Wiemer, E.A.C.5
Stoter, G.6
Nooter, K.7
-
27
-
-
0035815988
-
A functional assay for detection of the mitoxantrone resistance protein, MXR (ABCG2)
-
DOI 10.1016/S0005-2736(01)00308-X, PII S000527360100308X
-
Robey, R. W.; Honjo, Y.; van de Laar, A.; Miyake, K.; Regis, J. T.; Litman, T.; Bates, S. E. A functional assay for detection of the mitoxantrone resistance protein, MXR (ABCG2) Biochim. Biophys. Acta, Biomembr. 2001, 1512, 171-182 (Pubitemid 32530764)
-
(2001)
Biochimica et Biophysica Acta - Biomembranes
, vol.1512
, Issue.2
, pp. 171-182
-
-
Robey, R.W.1
Honjo, Y.2
Van De Laar, A.3
Miyake, K.4
Regis, J.T.5
Litman, T.6
Bates, S.E.7
-
28
-
-
0021061819
-
Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
-
Mosmann, T. Rapid colorimetric assay for cellular growth and survival. Application to proliferation and cyto-toxicity assays J. Immunol. Methods 1983, 65, 55-63 (Pubitemid 14203433)
-
(1983)
Journal of Immunological Methods
, vol.65
, Issue.1-2
, pp. 55-63
-
-
Mosmann, T.1
|